Bodipy-FL-verapamil: A fluorescent probe for the study of multidrug resistance proteins

Cellular Oncology

Volumn 26, Issue 1-2, 2004, Pages 3-11

  Rosati, Anna ^a   Candussio, Luigi ^a   Crivellato, Enrico ^b   Klugmann, Fiora Bartoli ^a   Giraldi, Tullio ^a   Damiani, Daniela ^c   Michelutti, Angela ^c   Decorti, Giuliana ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Bodipy FL verapamil; Cytofluorimetry; MRP; Multidrug resistance; P glycoprotein

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; FLUORESCENT DYE; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; TIOGUANINE; UNCLASSIFIED DRUG; VERAPAMIL; VERAPAMIL 4,4 DIFLUORO 5,7 DIMETHYL 4 BORA 3A,4A DIAZA S INDACENE 3 PENTANOIC ACID SUCCINIMIDYL ESTER; VERLUKAST; VINBLASTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; DRUG TRANSPORT; DRUG UPTAKE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LEUKEMIA; MICE; MICROSCOPY, FLUORESCENCE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PREDICTIVE VALUE OF TESTS; PROBENECID; PROPIONATES; QUINOLINES; SUS SCROFA; UP-REGULATION; VERAPAMIL; VINBLASTINE;

EID: 4243160658     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. M.R. Abbaszadegan, B.W. Futscher, W.T. Klimecki, A. List and W.S. Dalton, Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells, Cancer Res. 54 (1994), 4676-4679.
2. J.D. Bailly, C. Muller, J.P. Jaffrezou, C. Demur, G. Gassar, C. Bordier and G. Laurent, Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines. Leukemia 9 (1995), 799-807.
3. P. Borst, R. Evers, M. Kool and J. Wijnholds, A family of drug transporters: The multidrug resistance-associated proteins, J. Nat. Cancer Inst. 92 (2000), 1295-1302.
4. P. Borst, R. Evers, M. Kool and J. Wijnholds, The multidrug resistance protein family, Biochim. Biophys. Acta Biomembranes 1461 (1999), 347-357.
5. D. Brugger, H. Herbart, V. Gekeler, G. Seitz, C. Liu, T. Klingebiel, T. Orlikowsky, H. Einsele, C. Denzlinger, P. Bader, D. Niethammer and J.F. Beck, Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts, Leukemia Res. 23 (1999), 467-475.
6. L. Candussio, E. Crivellato, A.M. Rosati, F.B. Klugmann, M. Granzotto, T. Giraldi and G. Decorti, Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells, Histochem. J. 33 (2001), 259-266.
7. Y. Canitrot, S. Lahmy, J.J. Buquen, D. Canitrot and D. Lautier, Functional study of multidrug resistance with fluorescent dyes. Limits of the assay for low levels of resistance and application in clinical samples. Cancer Lett. 106 (1996), 59-68.
8. T.C. Chambers, E.M. McAvoy, J.W. Jacobs and G. Eilon, Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells, J. Biol. Chem. 265 (1990), 7679-7686.
9. C.W. Cho, Y. Liu, X.D. Yan, T. Henthorn and K.Y. Ng, Carrier-mediated uptake of rhodamine 123: Implications on its use for MDR research, Biochem. Biophys. Res. Commun. 279 (2000), 124-130.
10. S.P.C. Cole and R.G. Deeley, Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP, Bioessays 20 (1998), 931-940.
11. E. Crivellato, L. Candussio, A.M. Rosati, F. Bartoli Klugmann, F. Mallardi and G. Decorti, The fluorescent probe Bodipy-FL-Verapamil is a substrate for both P-glycoprotein and multidrug resistance-related protein (MRP)-1, J. Histochem. Cytochem. 50 (2002), 731-734.
12. E. Crivellato, L. Candussio, A.M. Rosati, G. Decorti, F.B. Klugmann and F. Mallardi, Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport, Histochem. J. 31 (1999), 635-643.
13. G. Decorti, I. Peloso, D. Favarin, F.B. Klugmann, L. Candussio, E. Crivellato, F. Mallardi and L. Baldini, Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line, J. Pharmacol. Exp. Ther. 286 (1998), 525-530.
14. G. Decorti, A. Rosati, L. Candussio, T. Giraldi and F. Bartoli Klugmann, Characterization of multidrug transporters in a normal renal tubular cell line resistant to doxorubicin. Multidrug transporters in the LLC-PK1 cell line and its resistant counterpart, Biochem. Pharmacol. 61 (2001), 61-66.
15. J.P. Delville, O. Pradier, O. Pauwels, A. Vanonderbergen, R. Kiss, W. Feremans and P. Capel, Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of Rhodamine 123, Am. J. Hematol 49 (1995), 183-193.
16. M.F. Fromm, P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs, Int. J. Clin. Pharmacol. Ther. 38 (2000), 69-74.
17. E.E. Gheuens, D.R. van Bockstaele, M. van der Keur, H.J. Tanke, A.T. van Oosterom and E.A. De Bruijn, Flow cytometric double labeling technique for screening of multidrug resistance, Cytometry 12 (1991), 636-644.
18. R.N. Hull, W.R. Cherry and G.W. Weaver, The origin and characteristics of a pig kidney cell strain, LLC-PK1, In Vitro 12 (1976), 670-677.
19. L.V. Johnson, M.L. Walsh, B.J. Bockus and L.B. Chen, Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy, J. Cell Biol 88 (1981), 526-535.
20. L.V. Johnson, M.L. Walsh and L.B. Chen, Localization of mitochondria in living cells with rhodamine 123, Proc. Natl. Acad. Sci. USA 77 (1980), 990-994.
21. S. Kajiji, J.A. Dreslin, K. Grizzuti and P. Gros, Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine 939/941, Biochemistry 33 (1994), 5041-5048.
22. D. Kessel, W.T. Beck, D. Kukuruga and V. Schulz, Characterization of multidrug resistance by fluorescent dyes, Cancer Res. 51 (1991), 4665-4670.
23. J.M. Kuhnel, J.Y. Perrot, A.M. Faussat, J.P. Marie and M.A. Schwaller, Functional assay of multidrug resistant cells using JC-1, a carbocyanine fluorescent probe, Leukemia 11 (1997), 1147-1155.
24. H.I. Lelong, A.P. Guzikowski, R.P. Haugland, I. Pastan, M.M. Gottesman and M.C. Willingham, Fluorescent verapamil derivative for monitoring activity of the multidrug transporter, Mol. Pharmacol. 40 (1991), 490-494.
25. M. Maynadie, G. Lizard, E. Solary, P. Roignot and P.M. Carli, Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: Comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines, Anticancer Res. 14 (1994), 2605-2609.
26. M. Michieli, D. Damiani, A. Ermacora, D. Raspadori, A. Michelutti, S. Grimaz, R. Fanin, D. Russo, F. Lauria, P. Masolini and M. Baccarani, P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells, Br. J. Haematol. 96 (1997), 356-365.
27. D.W. Miller, M. Fontain, C. Kolar and T. Lawson, The expression of multidrug resistance-associated protein (MRP) in pancreatic adenocarcinoma cell lines. Cancer Lett. 107 (1996), 301-306.
28. A.A. Neyfakh, Use of fluorescent dyes as molecular probes for the study of multidrug resistance, Exp. Cell Res. 174 (1988), 168-176.
29. J. Petriz and J. Garcia Lopez, Flow cytometric analysis of P-glycoprotein function using rhodamine 123, Leukemia 11 (1997), 1124-1130.
30. A. Rosati, G. Decorti, F.B. Klugmann, L. Candussio, M. Granzotto, M. Melato and T. Giraldi, Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart. Anticancer Res. 20 (2000), 3403-3410.
31. I. Sugawara, S. Akiyama, R.J. Scheper and S. Itoyama, Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP, Cancer Lett. 112 (1997), 23-31.
32. A. Tafuri, A. Sommaggio, L. Burba, M.P. Albergoni, M.T. Petrucci, M.G. Mascolo, A.M. Testi and G. Basso, Prognostic value of rhodamine-efflux and MDR-1/P-170 expression in childhood acute leukemia. Leukemia Res. 19 (1995), 927-931.
33. D.F. Tang-Wai, S. Kajiji, F. Di Capua, D. de Graaf, I.B. Roninson and P. Gros, Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators. Biochemistry 34 (1995), 32-39.
34. Y. Tanigawara, Role of P-glycoprotein in drug disposition, Ther. Drug Monit. 22 (2000), 137-140.
35. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan and M.C. Willingham, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues, Proc. Natl. Acad. Sci. USA 84 (1987), 7735-7738.
36. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan and M.C. Willingham, Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein, J. Histochem. Cytochem. 37 (1989), 159-164.
37. X.Y. Xie, D. Robb, S. Chow and D.W. Hedley, Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia 9 (1995), 1882-1887.
38. G.J.R. Zaman, M.J. Flens, M.R. Vanleusden, M. Dehaas, H.S. Mulder, J. Lankelma, H.M. Pinedo, R.J. Scheper, F. Baas, H.J. Broxterman and P. Borst, The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump, Proc. Natl. Acad. Sci. USA 91 (1994), 8822-8826.